Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Off-Label Cancer Drug Policy Will Have “Very Narrow” Focus

Executive Summary

The Centers for Medicare & Medicaid Services' pending policy decision on coverage of off-label cancer drugs will have a "very narrow" focus, Coverage & Analysis Group Director Steve Phurrough, MD, told the Schwab Soundview Washington Research Group health care conference May 6

You may also be interested in...



CMS Wants Data On Rx Efficacy In Seniors; McClellan Asks AMA To Help

CMS' outcomes research priorities include developing real world data on the effectiveness of drugs in seniors, agency Administrator Mark McClellan told an American Medical Association conference in Washington, D.C. March 30

Zevalin Price Negotiations Will Be Model For Medicare Part B, Scully Says

Idec's experience securing Medicare reimbursement for Zevalin should be considered the model for how coverage decisions will work for new products once Part B payment reforms are implemented in 2005, former CMS Administrator Tom Scully said

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS043962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel